Nicotine attenuates disruption of blood-brain barrier induced by saturated-fat feeding in wild-type mice

Nicotine and Tobacco Research

Volumn 17, Issue 12, 2015, Pages 1436-1441

  Elahy, Mina ^a,b   Lam, Virginie ^a,b   Pallebage Gamarallage, Menuka M ^b   Giles, Corey ^a,b   Mamo, John C L ^a,b   Takechi, Ryusuke ^a,b  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN G; NICOTINE; SATURATED FATTY ACID; FAT INTAKE; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER INTEGRITY; BRAIN DYSFUNCTION; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EXTRAVASATION; FAT INTAKE; FEMALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM PARAMETERS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; TOXICITY;

ANIMALS; BLOOD-BRAIN BARRIER; DIETARY FATS; FATTY ACIDS; FEMALE; MICE; MICE, INBRED C57BL; NICOTINE;

EID: 84973115855     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv044     Document Type: Article

References (29)

1. Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Mamo JC. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk. Prog Lipid Res. 2010;49(2):159-170. doi:10.1016/j.plipres.2009.10.004.
2. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12(12):723-738. doi:10.1038/nrn3114.
3. Nerurkar PV, Johns LM, Buesa LM, et al. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J Neuroinflammation. 2011;8:64. doi:10.1186/1742-2094-8-64.
4. Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ. Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem. 2006;99(2):438-449. doi:JNC4079[pii]10.1111/j.1471-4159.2006.04079.x.
5. Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Agingrelated changes in blood-brain barrier integrity and the effect of dietary fat. Neurodegener Dis. 2013;12(3):125-135. doi:10.1159/000343211.
6. Takechi R, Galloway S, Pallebage-Gamarallage MM, et al. Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding. Clin Exp Pharmacol Physiol. 2013;40(1):45-52. doi:10.1111/1440-1681.12032.
7. Pallebage-Gamarallage M, Lam V, Takechi R, et al. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis. 2012;11:117. doi:10.1186/1476-511X-11-117.
8. Pallebage-Gamarallage MM, Takechi R, Lam V, et al. Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk. Atheroscler Suppl. 2010;11(1):49-54. doi:10.1016/j.atherosclerosissup.2010.04.002.
9. Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Longterm probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction. Lipids Health Dis. 2014;13:91. doi:10.1186/1476-511X-13-91.
10. Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice. J Neuroinflammation. 2013;10:73. doi:10.1186/1742-2094-10-73.
11. Mazzone P, Tierney W, Hossain M, et al. Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area. Int J Environ Res Public Health. 2010;7(12):4111-4126. doi:10.3390/ijerph7124111.
12. Naik P, Fofaria N, Prasad S, et al. Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe? BMC Neurosci. 2014;15:51. doi:10.1186/1471-2202-15-51.
13. Lain KY, Powers RW, Krohn MA, et al. Urinary cotinine concentration confirms the reduced risk of preeclampsia with tobacco exposure. Am J Obstet Gynecol. 1999;181(1, pt 5):1192-1196.
14. Hjern A, Hedberg A, Haglund B, Rosen M. Does tobacco smoke prevent atopic disorders? A study of two generations of Swedish residents. Clin Exp Allergy. 2001;31(6):908-914.
15. Shim SB, Lee SH, Chae KR, et al. Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice. Neurochem Res. 2008;33(9):1783-1788. doi:10.1007/s11064-008-9629-5.
16. Arendash GW, Sanberg PR, Sengstock GJ. Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav. 1995;52(3):517-523.
17. Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging. 1995;16(5):857-860.
18. Nordberg A, Hellstrom-Lindahl E, Lee M, et al. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem. 2002;81(3):655-658.
19. Ono K, Hasegawa K, Yamada M, Naiki H. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Biol Psychiatry. 2002;52(9):880-886.
20. Quik M, Parameswaran N, McCallum SE, et al. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. J Neurochem. 2006;98(6):1866-1875. doi:10.1111/j.1471-4159.2006.04078.x.
21. de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology. 2006;67(2):315-318. doi:10.1212/01. wnl.0000225050.57553.6d.
22. Naddafi F, Reza Haidari M, Azizi G, Sedaghat R, Mirshafiey A. Novel therapeutic approach by nicotine in experimental model of multiple sclerosis. Innov Clin Neurosci. 2013;10(4):20-25.
23. Takechi R, Galloway S, Pallebage-Gamarallage MM, et al. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta. Br J Nutr. 2010;103(5):652-662. doi:10.1017/S0007114509992194.
24. Heeschen C, Weis M, Cooke JP. Nicotine promotes arteriogenesis. J Am Coll Cardiol. 2003;41(3):489-496.
25. Sharentuya N, Tomimatsu T, Mimura K, et al. Nicotine suppresses interleukin-6 production from vascular endothelial cells: a possible therapeutic role of nicotine for preeclampsia. Reprod Sci. 2010;17(6):556-563. doi:10.1177/1933719110362594.
26. Wang Y, Zhang F, Yang W, Xue S. Nicotine induces pro-inflammatory response in aortic vascular smooth muscle cells through a NFkappaB/osteopontin amplification loop-dependent pathway. Inflammation. 2012;35(1):342-349. doi:10.1007/s10753-011-9324-6.
27. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radical Res. 2009;43(4):348-364. doi:10.1080/10715760902751902.
28. Yao PM, Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem. 2001;276(45):42468-42476. doi:10.1074/jbc.M101419200 M101419200 [pii].
29. Morgan NG. Fatty acids and beta-cell toxicity. Curr Opin Clin Nutr Metab Care. 2009;12(2):117-122. doi:10.1097/MCO.0b013e328321e423